Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | HSP90AB1 | P08238 | 4/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 5/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | TLR4 | O00206 | 1/20 | 0.38 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.38 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.38 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.36 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4979983 | 0.99 | KDM4E (0.43) | KDM4EALDH1A1HSD17B10PTPN11MAPT | |
| SCHEMBL4980586 | 0.90 | ALDH1A1 (0.51) | KDM4EALDH1A1PTPN11MAPTHSP90AB1 | |
| SCHEMBL4978718 | 0.88 | HSP90AA1 (0.43) | PTPN11MAPTHSP90AB1HSP90AA1TLR4 | |
| SCHEMBL4980295 | 0.86 | HSP90AA1 (0.42) | PTPN11MAPTHSP90AB1HSP90AA1TLR4 | |
| SCHEMBL4977945 | 0.85 | HCRTR1 (0.47) | ALDH1A1PTPN11MAPTHSP90AB1HSP90AA1 | |
| SCHEMBL4977918 | 0.85 | KDM4E (0.48) | KDM4EPTPN11MAPTHSP90AB1HSP90AA1 | |
| SCHEMBL4974941 | 0.84 | HCRTR1 (0.48) | PTPN11MAPTHSP90AB1HSP90AA1TLR4 | |
| SCHEMBL4980266 | 0.84 | HCRTR1 (0.48) | PTPN11MAPTHSP90AB1HSP90AA1TLR4 | |
| SCHEMBL4976378 | 0.84 | MAPT (0.43) | MAPTHSP90AB1HSP90AA1TLR4TLR9 | |
| SCHEMBL4976398 | 0.84 | HCRTR1 (0.45) | PTPN11MAPTHSP90AB1HSP90AA1TLR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080051387-A1 | TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES | NEUROGEN CORPORATION | 2008-02-28 | — | — | US | disclosed |
| US-20080051387-A1 | TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES | NEUROGEN CORPORATION | 2008-02-28 | — | — | US | disclosed |
| US-20080051387-A1 | TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES | NEUROGEN CORPORATION | 2008-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080051387-A1 | TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES | HRH3, HRH4, HRH2 | KDM4E 1865/4885ALDH1A1 1142/4885HSD17B10 4078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.